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events (x2 = 25, p = 0.0001) and death (X2 = 21, p = 0.001); while the
presence of ischemia (X2= 11,p= 0.001) as the best predictor of soft events.
The 4 year hard event free survival was 90% in pts with large defects and
97% in Pts with no or small defects (p = 0.01). The 4 year freedom from
revaecularization was 78% in pts with ischemia and in pts with no ischemia
(p= 0.05).
Thus, the predictors of ham’andsoftevents are different in pts with stable
CAD. The perfusion defect size, a marker of LV function, is an important
predictor of death while ischemia is a more important predictor of other
events.
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D941 140 MyocardialProstsglandinReceptors(EP3Subtype)Inhibit the Inotropic Effect of
&Adrenergic Stimulation
T. Hohlfeld, K. Schr&. hrstitut ftir Phmrna/ro/ogie,
Heinrich-Heine-Univemit4 Dusseldorf, Germany
Proateglandin receptors (EP3 subtype) have recently been identified in the
human heart. The functional role of these receptors, however, is unknown.
In order to examine cardiac EP3 receptor function, prostaglandin (PG) EI
(1 nmol/min) wee infused into the IAD of anesthetised open-chest minipigs.
Heaft rate, systolic blood pressure and regional contractile activity (sonomi-
crometric crystals, area suppliedbytheLAD) were not changedatbaseline
conditions.In contrast, PGEI markedly decreased the inotropic effect of
3 @rein isoprenaline (iv.) by 74 * 18% (n = 5, p c 0.05 vs. control).
Following pretreatment with reserpine (50 r.@kg, iv., 8 h before surgery),
PGEi was equally effective (85+ 8Y0reduction of isoprenaline-stimulatad
contractility, n = 4, p <0.05 vs. control), suggesting a postsynaptic effect
of PGE1. The EP3 receptor-selectiveagonistM&B 28.787 (1 nmol/min, i.e.)
also decreased the inotropic action of isoprenaline by a similar extent, while
butaprost (5 nmollmin, i.e., selective for EP2receptors)did not.This indicates
that myocardial EP3 receptors mediate the obsewed negative inotropic ac-
tion of PGEI. The positive inotropic action of the phosphodiesteraae inhibitor
milrinone (0.2 mgikg, iv.), but not of ouabain (10 wdkg, iv.), was also inhib-
ited by PGE1, suggesting that myocardial EP3 receptors selectively reduce
cAMP-mediatad contractile effacfe. This was confirmed by in vitro exper-
iments, ahowing an inhibition of earcolemmal membrane cAMP formation
by PGEt (ECSO= 2.5 nM). It is concluded that myocardial EP3 receptors
inhibit cAMP-mediated inotropic effects. This provides a rational explanation
of the well-established antiischemic action of endogenous and exogenous
proeteglandins.
m941 141 PulmonaryArteryBandingUpregulateeVaacularEndotheliaiGrowth Factor and ita Flkl Receptor
in Pig Haarts
S. Kuki, E.P. Bauer, M. Arras, R. Zimmerman, W. Schapar.
Mex-Planck-institute, Bad Nauheim, Germany
Although vascular endothelial growth factor (VEGF) is a potent and specific
endothelial mitogen that is able to induce angiogenesis, little is known ra-
garding the role of VEGF in in vivo cardiac hypertrophy which requires a
propcmionai coronaty artety growth. We investigated the gene expression
of VEGF and its Flkl and Fltl receptors using right ventricular hypertrophy
(RVH) after pulmonary artwy banding (PAB) in pigs, which exhibit a coronary
artery anatomy and distribution similar to humans. 35 pigs (5 groups) were
used, each group included 4 bandad (B) and 3 eham (S)-pigs. Pigs were
killed at 2h, Id, 3d, 7d, and 24d after PAB. RV/(lVS + LV) in weight was usad
for index of RVH. VEGF, Flkl, Fltl and atrial natriuretic factor (ANF) mRNA
were analyzed by Northern blot hybridization. Mean trans-banding pressure
TimeafterPAB
2h Id 3d 7d 24d
RV/(lVS+LV) 1.07 1.0 1.31 1.65** 1.63**
ANF/18S 1.12 2.42** 5.24”* 1.63 1.14
VEGF/18S 2.03”” 1,57 1,11 0.95 1.06
Flkll18S 1.56” 2.53** 1.64*” 1.04 1.18
Values(mesn)forS sraexpreseedssfold-increseeoverS. *p <0.05, ** p <0.01 vsS.
gradient was 29 mmHg. Significant RVH wae observed within the first week
after PAB.The expreeeion of ANF in RV wae transiently obsemd during the
development of RVH, but not in the established RVH. The rapid induction of
VEGF and the following persistent expression of Flkl were obsewad prior
to progression of RVH. In addition, we investigated transmural distribution of
these mRNAs at 2h after PAB, however, there were no differences in mRNAa
level between subendo&ardiurn and subepicardiurr,r.The expression of FM
could not be observed, The extremely rapid expression of the Iigand and
receptor mRNA before hypertrophy suggeet functions of the VEGF-system
in addition to angiogenesis.
[941-1~ DeWeaeeCfLeVelsof lKAc~mRhlAinPatientsvvith
Chronic Atrial Fibrillation but no Changes in the
Sercoplaamic Reticulum Calcium ATPase and
Phospholamban
B.J. Brundel, I.C. Van Gelder, R.H, Henning, L.E. Deelman,
A.E. Tuinenburg, W.H. Van Gilst, H.J. Crijns. Dept. of Cardio/ogyand
Clinical Pharmacology, Thoraxcentec fJniveraify Hoapita/ Gronirrgan, The
Natherfands
Impairment of atrial and ventricular function is an important consequence of
atrial fibrillation (AF). This maybe caused by a tachycardiomyopathy (TCM).
Nodataonthe underlying mechanism are available. The aim of this atudyisto
investigate mRNA Ievela of proteins influencing the calcium and potassium
handling, sarcoplasmic reticulum calcium ATPase (SERCA), phospholam-
ban (Pi) and one WmpOflent Ofthe iKAch,the cardiac inward rectifier (CIR).
Right atrial appendages (RAA) wera obtained from 18 patients with AF and
from 19 controls in einus rhythm who were matched for age, sex, undetfy-
ing disease, drugs and functional class.Previous duration of AF was 9 *
3 months. Total RNA of RAA was isolated and reversely transcribed into
cDNA. In a single semi-quantitative polymerase chain reaction the mRNA of
interest and of glycereldehyde-3-phosphate dehydrogenaee (GAPDH) were
coamplified and eepareted by gel-electrophoresis. cDNAa of the ethidium
bromide stained gels were quantified by densitrometry. The CIR mRNAcon-
tent was significantly reduced (–38%, p c 0.05). SERCAand PI mRNA Ievele
were unchanged. GAPDH levels were identical for both groups. Conclusion:
chronic AF did not affect mRNA levels of SERCAand P1.However, the mRNA
level of one component of IKKW (CIR) was significantly downregulated in the
RAA of patients suffering from chronic AF.
/941-143/ lnVOlvementOfJanuSkina*S (Jak)in (Jrokinass
Receptor (uPAR) Signaling - A Novel Pathway to
Alter Gene Expression in the Development of
Atherosclerosis?
A. Weis, 1.Dumler, R. Diefz, D.C. Gulba. Humboldt l/niversityat Berlin,
Berlin, Germany
The binding of urokinase-type plaeminogen activator (uPA) to cell surfacea
via its specific receptor (uPAR) facilitates migration, invasion and matrix
degradation for vascular smooth muacle cells (SMCS) and endothelial cells
(ECe)- kay events in atherosclerosis and in intimal thickening after vascular
injuty. However, the exact signaling pathwaye of the uPA/uPAR syatem are
so far unknown. This etudy proposee a role for the Jak/STAT pathway in
the uPAR-mediated signaling by providing a cloee association of the Janus
kinases Jakl and Tyk2 with the uPAR in human aortic SMCS and human
umbilical vein ECe. Cell Iysates of a primary culture of SMCe and ECSwere
immunoprecipitatad with anti-uPAR monoclinal antibodies. Precipitated pro-
teins were separated by gel electrophoreeie, transferred to a PVDF mem-
brane, immunoblottad with polyclonal anti-Jakl, anti-Jak2, anti-Jak3, and
anti-Tyk2 antibodies, and viaualizad by chemi-luminescent etaining. There
wae a close association of uPAR with Jakl and Tyk2 in both SMCe and ECS
cell Iysatee,but not with Jak2 and Jak3.
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